Free Trial

Utah Medical Products (UTMD) Stock Price, News & Analysis

Utah Medical Products logo
$64.18 -0.51 (-0.79%)
(As of 11/20/2024 ET)

About Utah Medical Products Stock (NASDAQ:UTMD)

Key Stats

Today's Range
$63.65
$64.33
50-Day Range
$63.38
$68.52
52-Week Range
$63.38
$87.21
Volume
11,682 shs
Average Volume
27,028 shs
Market Capitalization
$217.57 million
P/E Ratio
15.03
Dividend Yield
1.87%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Utah Medical Products Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
69th Percentile Overall Score

UTMD MarketRank™: 

Utah Medical Products scored higher than 69% of companies evaluated by MarketBeat, and ranked 343rd out of 963 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Utah Medical Products.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Utah Medical Products is 15.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.38.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Utah Medical Products is 15.03, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 130.53.

  • Price to Book Value per Share Ratio

    Utah Medical Products has a P/B Ratio of 1.82. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Utah Medical Products' valuation and earnings.
  • Percentage of Shares Shorted

    1.75% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Utah Medical Products has recently decreased by 0.87%, indicating that investor sentiment is improving.
  • Dividend Yield

    Utah Medical Products pays a meaningful dividend of 1.82%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Utah Medical Products does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Utah Medical Products is 28.10%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Utah Medical Products' dividend.
  • Percentage of Shares Shorted

    1.75% of the float of Utah Medical Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Utah Medical Products has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Utah Medical Products has recently decreased by 0.87%, indicating that investor sentiment is improving.
  • News Sentiment

    Utah Medical Products has a news sentiment score of 1.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Utah Medical Products this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for UTMD on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.60% of the stock of Utah Medical Products is held by insiders.

  • Percentage Held by Institutions

    69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Utah Medical Products' insider trading history.
Receive UTMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Utah Medical Products and its competitors with MarketBeat's FREE daily newsletter.

UTMD Stock News Headlines

Utah Medical Products appoints Carrie Leigh to board of directors
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
Utah Medical Products, Inc.
See More Headlines

UTMD Stock Analysis - Frequently Asked Questions

Utah Medical Products' stock was trading at $84.22 at the beginning of the year. Since then, UTMD shares have decreased by 23.8% and is now trading at $64.18.
View the best growth stocks for 2024 here
.

Utah Medical Products, Inc. (NASDAQ:UTMD) issued its quarterly earnings results on Thursday, April, 25th. The medical instruments supplier reported $0.84 EPS for the quarter. The medical instruments supplier earned $10.73 million during the quarter. Utah Medical Products had a net margin of 34.62% and a trailing twelve-month return on equity of 12.10%.

Utah Medical Products' top institutional investors include FMR LLC (7.72%), Geode Capital Management LLC (2.86%), Hotchkis & Wiley Capital Management LLC (2.63%) and Rice Hall James & Associates LLC (2.39%). Insiders that own company stock include Paul O Richins, Barbara A Payne and Ernst G Hoyer.
View institutional ownership trends
.

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AUO (AUOTY).

Company Calendar

Last Earnings
4/25/2019
Ex-Dividend for 10/4 Dividend
9/20/2024
Dividend Payable
10/04/2024
Today
11/20/2024
Ex-Dividend for 1/3 Dividend
12/16/2024
Fiscal Year End
12/31/2024
Dividend Payable
1/03/2025
Next Earnings (Estimated)
2/04/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:UTMD
CUSIP
91748810
Employees
180
Year Founded
N/A

Profitability

Net Income
$16.64 million
Pretax Margin
41.30%

Debt

Sales & Book Value

Annual Sales
$50.22 million
Cash Flow
$6.16 per share
Book Value
$35.35 per share

Miscellaneous

Free Float
3,168,000
Market Cap
$217.57 million
Optionable
Not Optionable
Beta
0.08

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:UTMD) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners